Veteran Overmedication and Suicide Prevention Act of 2025
This bill requires the Department of Veterans Affairs (VA) to commission an independent review by the National Academies of Sciences, Engineering, and Medicine into the suicides and violent/accidental deaths of veterans treated by the VA during a five-year period ending in 2025. The review will analyze medication use (including drugs with serious safety warnings), treatment approaches for conditions like PTSD, mental health staffing levels, and data-sharing practices across VA facilities and state programs. It mandates a detailed report on findings, including patterns in overprescribing, effectiveness of non-medication treatments, and facility-specific prescription rates, to be submitted to Congress and made public within 30 days of completion. The bill directly affects veterans who died by suicide or violent/accidental death while receiving VA care during the specified period.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
President
Introduced Jan 3, 2025
Last action Feb 3, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Feb 3, 2025
Committee
Referred to the Subcommittee on Health.
lower
Jan 3, 2025
Committee
Referred to the House Committee on Veterans' Affairs.
lower
Jan 3, 2025
Introduced
Introduced in House
lower
1 primary · 5 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 136
Scope: US
Hi! I can help you understand HR 136. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline